Pembrolizumab Plus Ramucirumab in Metastatic Gastric Cancer
Clinical trial NCT04632459 · COMPLETED
Trial details
- NCT number
- NCT04632459
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-16
- Primary completion
- 2025-01-09
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.